DAGMAR MOUSSARD: Open Payments
NPI 1750938486 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,952 in 85 payments from 13 companies in 2025. Trend: 2023 $1,521 · 2024 $1,743 · 2025 $1,952
Food & beverage: $1,784Education: $168
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $437 |
| ABBVIE INC. | 21 | $372 |
| Novartis Pharmaceuticals Corporation | 12 | $221 |
| Arcutis Biotherapeutics, Inc. | 8 | $198 |
| LEO Pharma Inc. | 7 | $157 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $141 |
| Organon LLC | 2 | $100 |
| Lilly USA, LLC | 3 | $78 |
| Galderma Laboratories, L.P. | 3 | $58 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $52 |
Products named: TREMFYA, SKYRIZI, Zoryve, ADBRY, COSENTYX, VTAMA, NEMLUVIO, TALTZ.
Industry payments across FL — which companies pay providers there.
